Tiodazosin is a potent and competitive postsynaptic alpha-adrenergic receptor antagonist; it inhibits norepinephrine-induced contractions in the mesenteric artery and portal vein, causing a rightward parallel shift in the concentration-response curve to norepinephrine in the mesenteric artery and a nonparallel inhibition with marked depression of maximal response in the portal vein.